Download PDF
Thromb Haemost 1975; 34(02): 378-385
DOI: 10.1055/s-0038-1651396
Original Article
Schattauer GmbH

Relation of the Fibrinolytic to Other Biological Systems[*]

Helge Stormorken
1   Institute for Thrombosis Research, Rikshospitalet, Oslo 1, Norway
› Author Affiliations
Further Information

Publication History

Received 01 July 1975

accepted 01 July 1975

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Postgraduate Course and Workshop “Progress in Fibrinolysis” Milan, March 6-8, 1975.


 

  • References

  • 1 Austen K. F. 1974; Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation. Transplantation Proceedings 6: 39.
    PubMedGoogle Scholar
  • 2 Beller F. K, and Glas P. 1961; The activation of plasminogen by urokinase (in comparison with previous observations with streptokinase). Thrombosis et Diathesis Haemorrhagica 5: 531.
    PubMedGoogle Scholar
  • 3 Bokisch V, Müller-Eberhardt H. J, and Cochrane C. G. 1969; Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. Journal of experimental Medicine 129: 1109.
    CrossrefPubMedGoogle Scholar
  • 4 Burrowes C. E, Movat H. Z, and Soltay H. J. 1971; The kinin system of human plasma. VI. The action of plasmin. Proceedings of the Society of experimental Biology and Medicine 138: 959.
    PubMedGoogle Scholar
  • 5 Cochrane C. G, and Wuepper K. D. 1971; The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman factor). Journal of experimental Medicine 134: 986.
    CrossrefPubMedGoogle Scholar
  • 6 Cochrane C. G, Revak S. D, Aikin B. S, and Wuepper K. D. 1972. In: Lepow I. H, and Ward P. A. (Eds.) Inflammation, mechanism and contici. Academic Press; N. Y.: 119.
    Google Scholar
  • 7 Cochrane C. G, Revak S. D, and Wuepper K. D. 1973; Activation of Hageman factor in solid and fluid phases. Journal of experimental Medicine 138: 1564.
    CrossrefPubMedGoogle Scholar
  • 8 Colman R. W. 1969; Activation of plasminogen by human plasma kallikrein. Biochemical Biophysical Research Communications 35: 273.
    CrossrefPubMedGoogle Scholar
  • 9 Donaldson V. H. 1968; Mechanisms of activation of C’l esterase in hereditary angioneurotic edema plasma in vitro: Role of Hageman factor, a clot promoting agent. Journal of experimental Medicine 127: 411.
    CrossrefPubMedGoogle Scholar
  • 10 Donaldson V. H, and Ratnoff O. D. 1970 Cit.
    PubMed
  • 00 Donaldson V. H. 1970. Blood coagulation and related plasma enzymes in inflammation. In: Jensen K. G, and Killman S.-Aa. (Eds.) Aspects of inflammation I. Series Haematologica. 3 39
    Google Scholar
  • 11 Fong J. S. C, White J. G, and Good R. A. 1974; Inhibition of endotoxin lipopoly-saccaride-mediated platelet aggregation by cobra venom anticomplementary factor. Blood 44: 399.
    PubMedGoogle Scholar
  • 12 Gjønnaess H, and Stormorken H. 1970; Blood clotting, plasma kinins and fibrinolysis. Thrombosis et Diathesis Haemorrhagica 24: 308.
    PubMedGoogle Scholar
  • 13 Godal H. C, and Theodor I. 1965; In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA). Scandinavian Journal of Clinical and Laboratory Investigation 17 (Suppl. 84) 199.
    CrossrefPubMedGoogle Scholar
  • 14 Hathaway W. E, Belhasen L. P, and Hathaway H. S. 1965; Evidence for a new plasma thromboplastin factor: I. Case report, coagulation studies and physico-chemical properties. Blood 26: 521.
    CrossrefPubMedGoogle Scholar
  • 15 Henson P. M. 1974; Complement-dependent platelet and polymorphonuclear leukocyte reactions. Transplantation Proceedings 6: 27.
    PubMedGoogle Scholar
  • 16 Herbert R. J, Ogston D, and Douglas A. S. 1972; Further purification and properties of Hageman factor cofactor. Biochemica Biophysica Acta 271: 371.
    CrossrefPubMedGoogle Scholar
  • 17 Herold R, and Straub P. W. 1972; In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis. Journal of Laboratory and clinical medicine 79: 397.
    PubMedGoogle Scholar
  • 18 Iatridis S. G, and Ferguson J. H. 1962; Active Hageman factor: A plasma lysokinase of the human fibrinolytic system. Journal of clinical Investigation 41: 1277.
    CrossrefPubMedGoogle Scholar
  • 19 Johnston A. R, Cochrane C. G, and Revak S. D. 1974; The relationship between Pf/dil and activated human Hageman factor. Journal of Immunology 113: 103.
    PubMedGoogle Scholar
  • 20 Kane M. A, May J. E, and Frank M. M. 1973; Interaction of the classical and alternate complement pathway with endotoxin lipopolysaccaride. Journal of clinical Investigation 52: 370.
    CrossrefPubMedGoogle Scholar
  • 21 Kaplan A. P, and Austen K. F. 1971; A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. Journal of experimental Medicine 133: 696.
    CrossrefPubMedGoogle Scholar
  • 22 Kaplan A. P, and Austen K. F. 1972; The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. Journal of experimental Medicine 136: 1378.
    CrossrefPubMedGoogle Scholar
  • 23 Laake K. 1975 Aspects of the in vitro functional interrelationship between the kallikreinkinin system, the fibrinolytic system, and the coagulation system of human plasma. Thesis. Oslo University Press.
    PubMedGoogle Scholar
  • 24 Laake K, and Vennerod A. M. 1974; Factor XII induced fibrinolysis: Studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma. Thrombosis Research 4: 285.
    CrossrefPubMedGoogle Scholar
  • 25 Laake K, and Østerud B. 1975 Activation of purified plasma factor VII by human plasman, plasma kallikrein, and activated components of the human intrinsic blood coagulation system. Thrombosis Research, in press.
    PubMedGoogle Scholar
  • 26 Leddy G. P, Frank M. M, Gaither T, Heuskinveld R. S, Breckenridge R. T, and Klemperer M. R. 1973; Hereditary deficiency of sixth component of complement (C6) in man. Journal of clinical Investigation 52: 50a.
    PubMedGoogle Scholar
  • 27 Malofiejew M. 1971; The biological and pharmacological properties of some fibrinogen degradation products. Scandinavian Journal of Haematology 8 (Suppl. 13) 303.
    PubMedGoogle Scholar
  • 28 Marcel G. A, Caspar C, Sabatier C, and Rapin M. 1973; Significance of kaolin-induced arginine esterase in human plasma during septic shock: Depletion in prekallikrein activator. Thrombosis Research 3: 281.
    CrossrefPubMedGoogle Scholar
  • 29 Margolis J. 1958; Activation of plasma by contact with glass: Evidence for a common reaction which releases plasma kinin and initiate coagulation. Journal of Physiology (Lond.) 144: 1.
    PubMedGoogle Scholar
  • 30 Niewiarowski S, and Prou-Wartelle O. 1959; Rôle du facteur contact (facteur Hageman) dans la fibrinolyse. Thrombosis et Diathesis Haemorrhagica 3: 593.
    PubMedGoogle Scholar
  • 31 Niewiarowski S, Senyi A. F, and Gillies P. 1973; Plasmin-induced platelet aggregation and platelet release reaction. Journal of clinical Investigation 52: 1647.
    CrossrefPubMedGoogle Scholar
  • 32 Ogston D, Ogston C. M, Ratnoff O. D, and Forbes C. D. 1969; Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform : the participation of Hageman factor and additional cofactors. Journal of clinical Investigation 48: 1786.
    CrossrefPubMedGoogle Scholar
  • 33 Prokopowicz J, and Stormorken H. 1968; Fibrinolytic activity of leucocytes in smears and bone marrow, and peripheral blood. Scandinavian Journal of Haematology 5: 129.
    PubMedGoogle Scholar
  • 34 Ratnoff O. D, Saito H, Waldman R, and Abraham J. P. 1975 Fitzgerald factor and Fitzgerald trait. Wayne State University Symposium 1975, in press.
    PubMedGoogle Scholar
  • 35 Ratnoff O. D, and Naff G. B. 1967; The conversion of Cls to CI esterase by plasmin and trypsin. Journal of experimental Medicine 125: 337.
    CrossrefPubMedGoogle Scholar
  • 36 Ratnoff O. D, and Miles A. A. 1964; The induction of permeability increasing activity in human plasma by activated Hageman factor. British Journal of experimental Pathology 45: 328.
    PubMedGoogle Scholar
  • 37 Ruddy S. 1974; Chemistry and biologic activity of the complement system. Transplantation Proceedings 6: 1.
    PubMedGoogle Scholar
  • 38 Saito H, Ratnoff O. D, and Donaldsson V. H. 1974; Defective activation of clotting, fibrinolytic and permeability enhancing systems in human Fletcher trait plasma. Circulation Research 34: 641.
    CrossrefPubMedGoogle Scholar
  • 39 Schiffman S, and Lee P. 1974; Preparation, characterization and activation of a highly purified factor XI: Evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII. British Journal of Haematology 27: 101.
    CrossrefPubMedGoogle Scholar
  • 40 Schreiber A. D, Kaplan A. P, and Austen K. F. 1973; Inhibition by CI INH of Hageman factor fragment activation of coagulation, fibrinolysis and kinin generation. Journal of clinical Investigation 52: 1402.
    CrossrefPubMedGoogle Scholar
  • 41 Soltay M. J, Movat H. Z, and Özge-Anwar A. H. 1971; The kinin system and human plasma V. The probable derivation of prekallikrein activator from activated Hageman factor (XIIa). Proceedings of the Society of experimental Biology and Medicine 138: 952.
    PubMedGoogle Scholar
  • 42 Stormorken H, Gjönnaess H, and Laake K. 1973/1974 Interrelations between the clotting and kinin systems. Activation of factor VII involving prekallikrein-kallikrein. Haemostasis 2: 245.
    PubMedGoogle Scholar
  • 43 Taylor F. B, and Müller-Eberhard H. J. 1970; Quantitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. Journal of clinical Investigation 49: 2068.
    CrossrefPubMedGoogle Scholar
  • 44 Ward P. A. 1967; A plasmin-split fragment of C 3 as a new chemotactic factor. Journal of experimental Medicine 126: 189.
    CrossrefPubMedGoogle Scholar
  • 45 Weiss A. S, Gallin J. I, and Kaplan A. P. 1974; Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity and kinin generation. Journal of clinical Investigation 53: 622.
    CrossrefPubMedGoogle Scholar
  • 46 Wendel IT, Vogt W, and Seidel G. 1972; Purification and some properties of a kininogenase from human plasma activated by surface contact. Hoppe-Seyler’s Zeitschrift für Physiologische Chemie 353: 1591.
    PubMedGoogle Scholar
  • 47 Witepper K. D. 1972. Biochemistry and biology of components of the plasma kinin system. In: Lepow I. H, and Ward P. A. (Eds.) Inflammation, mechanism and control. Academic Press; N. Y.: 93
    Google Scholar
  • 48 Zimmerman T. S, Arroyave C. M, and Müller-Eberhardt H. J. 1971; Blood coagulation abnormality in rabbits deficient in the sixth component of complement (C 6) and its correction by purified C6. Journal of experimental Medicine 134: 1591.
    CrossrefPubMedGoogle Scholar